We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$14.1B
AUM Growth
-$90M
Cap. Flow
-$394M
Cap. Flow %
-2.79%
Top 10 Hldgs %
21.48%
Holding
1,980
New
111
Increased
767
Reduced
962
Closed
123

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.3M
2
AAPL icon
Apple
AAPL
+$12.5M
3
LVS icon
Las Vegas Sands
LVS
+$10.1M
4
XOM icon
ExxonMobil
XOM
+$9.07M
5
ADP icon
Automatic Data Processing
ADP
+$7.98M

Sector Composition

Rank Sector Weight
1 Technology 28.17%
2 Healthcare 8.93%
3 Consumer Discretionary 8.08%
4 Financials 7.53%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPEN icon
1851
Opendoor
OPEN
$3.97B
$31.8K ﹤0.01%
17,881
+3,551
+25% +$7.66K
AMLX icon
1852
Amylyx Pharmaceuticals
AMLX
$2.43B
$29.4K ﹤0.01%
15,448
-890
-5% -$1.73K
LAZR
1853
DELISTED
Luminar Technologies
LAZR
$27.2K ﹤0.01%
1,216
-192
-14% -$4.55K
GSAT icon
1854
Globalstar
GSAT
$10.8B
$12K ﹤0.01%
+712
New +$12.8K
DNA.WS
1855
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$11.3K ﹤0.01%
399,600
AGX icon
1856
Argan
AGX
$8.66B
-11,979
Closed -$605K
AIN icon
1857
Albany International
AIN
$1.79B
-2,328
Closed -$218K
AKBA icon
1858
Akebia Therapeutics
AKBA
$354M
-1,039
Closed -$1.9K
OSG
1859
Octave Specialty Group
OSG
$253M
-86,234
Closed -$1.35M
ARCB icon
1860
ArcBest
ARCB
$3.23B
-1,907
Closed -$272K
ARES icon
1861
Ares Management
ARES
$32.2B
-2,420
Closed -$322K
ATEN icon
1862
A10 Networks
ATEN
$2.21B
-24,650
Closed -$337K
BBN icon
1863
BlackRock Taxable Municipal Bond Trust
BBN
$983M
-799,077
Closed -$13.1M
BDC icon
1864
Belden
BDC
$4.98B
-8,614
Closed -$798K
BMBL icon
1865
Bumble
BMBL
$417M
-13,146
Closed -$149K
BN icon
1866
Brookfield
BN
$109B
-10,060
Closed -$281K
BOH icon
1867
Bank of Hawaii
BOH
$3.19B
-3,411
Closed -$213K
BRKR icon
1868
Bruker
BRKR
$7.66B
-2,344
Closed -$220K
CCRN
1869
DELISTED
Cross Country Healthcare
CCRN
-11,284
Closed -$211K
CNI icon
1870
Canadian National Railway
CNI
$77B
-1,812
Closed -$239K
COIN icon
1871
Coinbase
COIN
$39.8B
-1,631
Closed -$432K
COLM icon
1872
Columbia Sportswear
COLM
$2.95B
-4,421
Closed -$359K
COOP
1873
DELISTED
Mr. Cooper
COOP
-9,457
Closed -$737K
CP icon
1874
Canadian Pacific Kansas City
CP
$79.7B
-10,142
Closed -$894K
CPA icon
1875
Copa Holdings
CPA
$5.98B
-2,175
Closed -$227K

Similar funds

Guggenheim Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Guggenheim Capital held 1,980 positions worth $14.1B, down 0.63% from $14.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Guggenheim Capital's Q2 2024 filing shows 111 new, 767 increased, 962 reduced and 123 closed positions. Its largest new stake was Arm: 48,961 shares worth $8.01M. The largest sale was VanEck Gold Miners ETF, an estimated $46.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q2 2024 buy was Arm: 48,961 shares worth $8.01M.
  • Guggenheim Capital added most to Microsoft in Q2 2024, an estimated $17.3M increase.
  • Guggenheim Capital's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $19.6M.
  • Guggenheim Capital fully exited VanEck Gold Miners ETF in Q2 2024, selling an estimated $46.2M.
  • Guggenheim Capital's ten largest holdings make up 21% of its $14.1B portfolio in Q2 2024.
  • Guggenheim Capital opened 111 new positions and closed 123 in Q2 2024.
  • Guggenheim Capital's portfolio value fell 0.63% quarter-over-quarter to $14.1B.

Based on Guggenheim Capital's 13F filing for Q2 2024, filed 14 Aug 2024.